Skip to main content
Nature Portfolio logoLink to Nature Portfolio
. 2024 Jan 10;5(1):210. doi: 10.1038/s43018-024-00724-1

Publisher Correction: A phase I/Ib trial and biological correlate analysis of neoadjuvant SBRT with single-dose durvalumab in HPV-unrelated locally advanced HNSCC

Laurel B Darragh 1,2, Michael M Knitz 1, Junxiao Hu 3, Eric T Clambey 4, Jennifer Backus 1, Andrew Dumit 1, Von Samedi 5, Andrew Bubak 6, Casey Greene 3,7, Timothy Waxweiler 1, Sanjana Mehrotra 5, Shilpa Bhatia 1, Jacob Gadwa 1, Thomas Bickett 1, Miles Piper 1, Kareem Fakhoury 1, Arthur Liu 8, Joshua Petit 8, Daniel Bowles 9, Ashesh Thaker 10, Kimberly Atiyeh 11, Julie Goddard 12, Robert Hoyer 9, Adrie Van Bokhoven 5, Kimberly Jordan 2, Antonio Jimeno 9, Angelo D’Alessandro 7, David Raben 1, Jessica D McDermott 9, Sana D Karam 1,2,
PMCID: PMC10824658  PMID: 38200246

Correction to: Nature Cancer 10.1038/s43018-022-00450-6, published online 25 November 2022.

In the version of the article initially published, the clinical trial protocol was missing and has now been added as Supplementary Information.

Supplementary information

Supplementary information

The online version contains supplementary material available at 10.1038/s43018-024-00724-1.

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials


Articles from Nature Cancer are provided here courtesy of Nature Publishing Group

RESOURCES